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Abstract
Expansion of GAA?TTC repeats within the first intron of the frataxin gene is the cause of Friedreich’s ataxia (FRDA), an
autosomal recessive neurodegenerative disorder. However, no effective treatment for the disease has been developed as
yet. In this study, we explored a possibility of shortening expanded GAA repeats associated with FRDA through
chemotherapeutically-induced DNA base lesions and subsequent base excision repair (BER). We provide the first evidence
that alkylated DNA damage induced by temozolomide, a chemotherapeutic DNA damaging agent can induce massive GAA
repeat contractions/deletions, but only limited expansions in FRDA patient lymphoblasts. We showed that temozolomide-
induced GAA repeat instability was mediated by BER. Further characterization of BER of an abasic site in the context of
(GAA)20 repeats indicates that the lesion mainly resulted in a large deletion of 8 repeats along with small expansions. This
was because temozolomide-induced single-stranded breaks initially led to DNA slippage and the formation of a small GAA
repeat loop in the upstream region of the damaged strand and a small TTC loop on the template strand. This allowed
limited pol b DNA synthesis and the formation of a short 5’-GAA repeat flap that was cleaved by FEN1, thereby leading to
small repeat expansions. At a later stage of BER, the small template loop expanded into a large template loop that resulted
in the formation of a long 5’-GAA repeat flap. Pol b then performed limited DNA synthesis to bypass the loop, and FEN1
removed the long repeat flap ultimately causing a large repeat deletion. Our study indicates that chemotherapeutically-
induced alkylated DNA damage can induce large contractions/deletions of expanded GAA repeats through BER in FRDA
patient cells. This further suggests the potential of developing chemotherapeutic alkylating agents to shorten expanded
GAA repeats for treatment of FRDA.
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Introduction
Friedreich’s ataxia (FRDA, OMIM 229300) is one of the most
prevalent inherited autosomal recessive neurodegenerative disor-
ders. The prevalence of FRDA is 1:50,000 in Caucasians, and it
has been estimated that the carrier rate can reach as high as 1:120-
1:60 [1–3]. The disease is caused by the silencing of the frataxin
gene [4], which further results in a low level of a 220-amino acid
mitochondrial protein, frataxin in cells. Because frataxin plays a
crucial role in maintenance of iron homeostasis, heme biosynthesis
and assembly of iron-sulfur clusters (ISCs) into metabolic enzymes
[5], cellular deficiency of the protein can lead to an insufficiency of
electrotransfer through a series of proteins and enzymes of the
respiratory chain. This subsequently increases electron leakage
that in turn results in energy deficiency and oxidative stress leading
to death of large sensory neurons in the dorsal root ganglia (DRG)
and the posterior columns of the spinal cord among others [6].
It has been found that frataxin gene expression is disrupted by
expanded GAA repeats located in the first intron of the frataxin
gene in FRDA patients [4]. The normal length of GAA repeats
ranges between 6 and 36, whereas the repeats in FRDA patients
can expand to up to 1700 repeat units with the majority of patients
bearing 600 to 900 triplets [4,7,8]. The level of mature frataxin
transcript and frataxin protein in FRDA patient cells is inversely
correlated with the length of GAA repeats, so that longer GAA
repeats lead to the lower levels of frataxin mRNA transcript and
frataxin protein [9]. In addition, the extent of GAA repeat
expansion correlates with disease severity and early age of onset
[7,10,11].
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Expanded GAA repeats in FRDA patients can form a variety of
unusual secondary structures, including purine:purine:pyrimidine
and pyrimidine:purine:pyrimidine triplexes [12–15] as well as
sticky DNA [16,17]. Moreover, the formation of RNA:DNA
hybrid triplexes can occur during transcription. This can sequester
RNA polymerase and transcription factors, impeding transcription
of the frataxin gene [17,18]. Expanded intronic GAA repeats can
also cause abnormal heterochromatinization [19,20] that subse-
quently leads to frataxin gene silencing. This is supported by the
observation that the hallmarks of heterochromatin such as DNA
methylation [21–24], histone deacetylation [25,26] and methyla-
tion of histone H3 lysine 9 [27,28] exist abundantly in the intronic
GAA repeats-containing region of the frataxin gene. Thus, GAA
repeat expansion can result in frataxin gene silencing, leading to a
deficiency of frataxin by directly interfering with its gene
transcription and/or facilitating the formation of heterochromatin
at the region near the promoter of the frataxin gene.
Expanded GAA repeats exhibit somatic instability that can be
age-dependent or age-independent. The mechanisms underlying
repeat instability remain elusive. It appears that DNA replication
[29], repair [30] and recombination [31] may play critical roles in
causing GAA repeat instability. It has been found that during
DNA replication, expanded GAA repeats resulted in replication
fork stalling when GAA repeats were in the lagging strand
templates [32–35]. This could in turn lead to the formation of
hairpin/loop structures on the newly synthesized strand or
template strand that further results in GAA repeat expansion
and deletion [33]. Thus, the formation of secondary structures
during DNA replication may be actively involved in modulating
GAA repeat instability. Recent findings of persistent post-
replicative junctions in human cells also point to the involvement
of several post-replicative mechanisms, such as single-stranded
DNA gap repair and/or double-stranded DNA break (DSB)
repair-mediated recombination in modulating GAA repeat
instability [36]. DSB repair in the context of GAA repeats resulted
in repeat deletions through end resectioning by single-stranded
exonuclease degradation of the repeats at the broken ends, or
through removal of repeat flaps that were generated by
homologous pairing [37]. This suggests that DSB repair is a
common mechanism that resolves replication stalling caused by
expanded GAA repeat tracts. This is further supported by a
finding showing that GAA repeat-induced recombination was
involved in chromosome fragility that is present in the human
genome, including in the frataxin gene [38]. In addition, expanded
GAA repeat tracts can be deleted by more than 50 bp via non-
homologous end joining of DSB intermediates during DNA
replication [39]. However, the age-dependent somatic instability
of GAA repeats in post-mitotic non-dividing tissues, such as dorsal
root ganglia [40], argues against a role for DNA replication in
modulating GAA repeat instability in these tissues. Several lines of
evidence have indicated that DNA mismatch repair (MMR) may
mediate somatic GAA repeat expansion. It was shown that the
absence of Msh2 or Msh6 proteins significantly reduced progres-
sion of GAA repeat expansion in the DRG and cerebellum in
FRDA transgenic mice [41]. Ectopic expression of MSH2 and
MSH3 in FRDA fibroblasts led to GAA repeat expansion in the
native frataxin gene, whereas knockdown of either MSH2 or
MSH3 gene expression using shRNA impeded the expansion [42].
In addition, it has been found that more MSH2, MSH3 and
MSH6 proteins are expressed in FRDA pluripotent stem cells
(iPSCs) that exhibit a high level of GAA instability than in their
parental fibroblasts [43,44]. Moreover, gene knockdown of either
MSH2 or MSH6 in FRDA iPSCs leads to a reduced rate of GAA
repeat expansions [43,45], which is consistent with the reduced
somatic GAA repeat expansions observed in the FRDA transgenic
mice with their Msh2 or Msh6 gene deleted [41]. This further
indicates that mismatch repair promotes somatic GAA repeat
expansions.
Currently adopted strategies for FRDA treatment are aimed at
correction of mitochondrial dysfunction through the use of a
variety of antioxidants and iron chelators [1,46], and intervention
of heterochromatin-mediated gene silencing via histone deacety-
lase (HDAC) inhibitors [47]. However, the effectiveness of these
therapeutic strategies is limited by expanded GAA repeats of
FRDA patients although they can ease the neurodegenerative
symptoms to some extent. A more effective therapy for the disease
needs to be developed. Interestingly, it has been found that an
expanded GAA repeat tract in peripheral blood cells and sperms
of some FRDA patients may be reverted back to the normal size
range by an unidentified mechanism [48,49]. This suggests that
deletion or shortening of expanded repeats can be employed as a
new effective treatment for FRDA. Thus, understanding the
mechanisms underlying GAA repeat contraction/deletion may
help develop effective therapeutic strategies that can shorten or
delete expanded large GAA repeat tracts, thereby restoring a
normal level of frataxin gene expression in DRG.
Trinucleotide repeats (TNRs) including GAA repeats are
tandem repeats containing guanines, which are hotspots of DNA
base damage such as alkylated and oxidized base lesions. A linkage
between DNA damage and somatic CAG and CTG repeat
contraction/deletion and expansion has been established in
bacteria [50], mammalian cells [51,52], and mouse models
[53,54]. Furthermore, it has been found that CAG repeat
expansion and deletion can be induced by the oxidized base
lesion 8-oxoguanine (8-oxoG) and mediated by DNA base excision
repair (BER) [52–57], a robust mechanism that combats the
adverse effects of oxidative DNA damage. Our previous studies
have demonstrated that CTG repeat instability is induced by the
oxidative DNA damaging agents, bromate, chromate and H2O2
with a tendency towards contraction, and is mediated by BER of
base lesions at different locations within CTG repeat tracts in
human cells [52]. This suggests that BER of DNA base lesions at
various locations can be actively involved in somatic deletion of
any type of TNRs. Because frataxin deficiency is directly
associated with elevated cellular oxidative stress in FRDA patients
[58,59], this may lead to an increased production of reactive
oxygen species (ROS) that in turn generates oxidized DNA base
lesions. We reason that oxidized DNA base lesions may account
for the age-dependent somatic instability of GAA repeats.
Moreover, because somatic deletion of expanded TNRs induced
by DNA base lesions may lead to the shortening of the expanded
repeats, it is possible that DNA damage-induced somatic TNR
deletion can be used as a new strategy for treatment of TNR-
related neurodegeneration such as FRDA. Thus, we further
hypothesize that DNA base lesions induced in expanded GAA
repeat tracts can result in GAA repeat deletion through BER. To
test this hypothesis, we have investigated whether BER of alkylated
DNA base lesions induced by the chemotherapeutic agent
temozolomide in the context of GAA repeats can induce deletion
of expanded GAA repeats in FRDA patient cells.
Temozolomide is an imidazoterazine-class chemotherapeutic
alkylating agent that is currently used for the treatment of
anaplastic astrocytoma and newly diagnosed glioblastoma [60]. It
causes cancer cell death by inducing DNA base lesions, including
N7-MeG (.70%), N3-MeA (9.2%) and O6-MeG (5%), through
methylation at the N7 position of guanine, the N3 position of
adenine, and the O6 position of guanine [61]. It has been found
that the majority of temozolomide-induced base lesions, N7-MeG
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and N3-MeA, are subjected to the BER pathway [62,63], and this
has been demonstrated as one of the major mechanisms
responsible for temozolomide chemotherapeutic resistance [64].
Thus, BER plays a crucial role in repairing temozolomide-induced
DNA base lesions. Here, we hypothesize that temozolomide can
induce multiple N7-MeGs and N3-MeAs in a long GAA repeat
tract in the genome of FRDA patient cells, which can be repaired
by BER. This would lead to repeat deletions, thereby shortening
GAA repeats. We found that temozolomide predominantly led to
large contractions, with only small expansions, in the intronic
GAA repeats of FRDA lymphoblasts. We further demonstrated
that the large repeat deletion was caused by the formation of a
large template loop structure along with a long GAA repeat flap
during BER. This allowed DNA polymerase b (pol b) to bypass the
template loop and flap endonuclease 1 (FEN1) to remove the long
flap resulting in a large deletion of GAA repeats. Our results reveal
a mechanistic basis for large GAA repeat deletions during BER of
alkylated DNA damage induced by a chemotherapeutic agent and
suggest a novel strategy of using BER-dependent GAA repeat
deletion for FRDA treatment.
Materials and Methods
Materials
Temozolomide was purchased from Sigma-Aldrich (St. Louis,
MO). RPMI 1640 medium with 2.05 mM L-glutamine and fetal
bovine serum (FBS) were purchased from Thermo Fisher Scientific
(Pittsburgh, PA). DNA oligonucleotides were synthesized by
Integrated DNA Technologies Inc. (Coralville, IA) and Eurofins
MWG Operon (Huntsville, AL). The radionucleotide [c-32P] ATP
(6000 Ci/mmol), cordycepin 5’-triphosphate 3’- [a-32P] (5000 Ci/
mmol) and deoxycytidine 5’-triphosphate [a-32P] (3000 Ci/mmol)
were purchased from PerkinElmer Inc. (Boston, MA). Micro Bio-
Spin 6 chromatography columns were from Bio-Rad (Hercules,
CA). Deoxynucleoside 59-triphosphates (dNTPs) were from Roche
Diagnostics (Indianapolis, IN). T4 polynucleotide kinase and
terminal nucleotidyltransferase were from Fermentas (Glen
Burnie, MD). Mung Bean Nuclease was from Epicenter (Madison,
WI). Normal-melting point agarose (NMPA), low-melting point
agarose (LMPA), and ethidium bromide were from Amresco
(Solon, OH). All other reagents were purchased from Sigma-
Aldrich (St. Louis, MO) and Thermo Fisher Scientific (Pittsburgh,
PA). Purified recombinant human apurinic/apyrimidinic endonu-
clease 1 (APE1), pol b, FEN1, and DNA ligase I (LIG I) were
generous gifts from Dr. Samuel H. Wilson at the National Institute
of Environmental Health Sciences, National Institutes of Health
(Research Triangle Park, NC) or were expressed and purified as
described previously [65].
Oligonucleotide substrates
DNA oligonucleotide substrates containing a tetrahydrofuran
(THF), an abasic site analog were designed to mimic an abasic site
that occurs in a (GAA)20 repeat tract or random DNA sequence. A
THF residue was used in this study because it is refractory to the
59-deoxyribosephosphate lyase activity of pol b. Thus, its repair
can only be subject to the long-patch BER sub-pathway that is
involved in mediating TNR instability after single-stranded DNA
(ssDNA) breaks are generated [56]. For a (GAA)20 repeat-
containing substrate, the guanine of the tenth GAA repeat was
substituted with a THF residue, whereas for a substrate containing
a random DNA sequence, the twenty-third nucleotide was
substituted by a THF residue. Substrates were constructed by
annealing an oligonucleotide with a THF residue to its template
strand at a molar ratio of 1:2. The sequences of the oligonucle-
otides are shown in Table S1.
Cell culture
Human lymphoblast cell lines GM02152 (a normal individual)
and GM16207 (FRDA patient with 280/830 GAA repeats) were
purchased from Coriell Institute for Medical Research (Camden,
NJ) and cultured in RPMI 1640 Medium supplemented with 15%
fetal bovine serum and 2.05 mM L-glutamine at 37uC under 5%
CO2.
Measurement of instability in intronic GAA repeats in the
normal and FRDA patient lymphoblasts
Instability of intronic GAA repeats induced by temozolomide
was determined by treating 46106 lymphoblasts derived from a
normal individual as well as a FRDA patient with expanded
GAA repeats with 10 mM temozolomide for 2 hr. A concentra-
tion of 10 mM temozolomide was chosen because at this dosage
the drug allowed $80% cell viability in the normal and FRDA
patient lymphoblasts. This ensured that enough cells would be
viable at the end of the experiments to isolate sufficient genomic
DNA from lymphoblasts for repeat sizing analysis. Cells were
then washed twice with phosphate-buffered saline (PBS),
supplied with fresh medium, and grown for 2 days to allow
DNA damage repair. The treatment was repeated three times
before cells were harvested. At the end of the experiments, cells
were harvested by centrifugation at 3000 rpm for 10 min.
Genomic DNA were isolated from cells using Wizard genomic
DNA purification kit (Promega, Madison, WI), dissolved in TE
buffer (10 mM Tris-HCl, pH 7.5, and 1 mM EDTA), and
stored at 220uC for subsequent size analysis. Untreated cells
served as a negative control. The experiments were repeated at
least 3 times.
Measurement of ssDNA breaks induced by
temozolomide using alkaline single cell gel
electrophoresis (comet assay)
The alkaline comet assay was conducted according to the
procedure described previously with minor modifications [66].
Briefly, cells were seeded in 6-well plates at a density of 106 per
well and treated with increasing concentrations of temozolo-
mide for 2 hr. Cells were then collected by centrifugation at
1500 rpm for 3 min. Subsequently, 20 ml of cell suspensions
were added into 80 ml 0.7% low-melting point agarose pre-
warmed at 37 uC to make cell-agarose mixture, which was then
spread onto a fully frosted microscope slide pre-coated with
0.8% normal-melting point agarose. After the agarose solidified,
the slides were immersed in freshly prepared lysis buffer (2.5 M
NaCl, 100 mM EDTA, 10 mM Tris, pH= 10.0, 1% sodium
sarcosinate, 1% Triton X-100, 10% DMSO) in the dark at 4 uC
for 1 hr. The slides were then soaked in the electrophoresis
buffer (300 mM NaOH, 1 mM EDTA, pH.13.0) for 30 min in
the dark to allow DNA unwinding. Subsequently, the slides were
subjected to electrophoresis for 30 min at 0.75 V/cm. Slides
were then washed with distilled water, stained with 40 ml of
ethidium bromide (20 mg/ml), and analyzed under a fluores-
cence microscope (Carl Zeiss, Oberkochen, Germany) at 2006
magnification. All the procedures were performed under the
dimmed light to prevent additional DNA damage. For each
treatment, 200 cells were randomly selected and scored to
calculate the comet rate (%) according to the equation: comet
rate (%) = total number of comet cells/200 counted cells,
whereas 30 comet cells were randomly chosen for analyzing the
Alkylated Base Lesions Cause GAA Repeat Deletions
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Olive Tail Moment (OTM) [67] with Comet Assay Software
Project (CASP, Free Software Foundation, Boston, MA). In our
study, necrotic and apoptotic cells were excluded according to
the criteria described by Olive and Banath [68]. The average
and standard error (S.E.) or standard deviation (S.D.) of comet
rate and OTM were obtained from three independent
experiments.
Measurement of BER capacity in the normal and FRDA
lymphoblasts
The normal lymphoblasts and FRDA lymphoblasts with
expanded GAA repeats were grown to near confluence. Cells
were harvested by centrifugation at 3000 rpm for 10 min and
washed twice with PBS. Cell extracts were made as described
previously [69] and were dialyzed into BER reaction buffer
containing 50 mM Tris-HCl, pH 7.5, 50 mM KCl, 0.1 mM
EDTA, 0.1 mg/ml bovine serum albumin, and 0.01% Nonidet P-
40. Substrates (25 nM) that contained a THF residue in the
random DNA sequence were pre-incubated with 50 nM purified
APE1 at 37uC for 30 min, and completely converted into ssDNA
break intermediates for subsequent BER reactions. In vitro BER of
a THF residue using FRDA lymphoblast cell extracts was
performed by incubating APE1 precut substrates with 60 mg cell
extracts at 37uC for 30 min in a 25-ml reaction mixture that
contained BER reaction buffer with 5 mM Mg2+, 50 mM dNTPs
and 50 mM [a-32P] dCTP. The reactions were terminated by
transferring to 95uC for 10 min in 25 ml of stopping buffer
containing 95% formamide and 2 mM EDTA. Subsequently, the
total 50 ml of reaction mixture were applied to Micro Bio-Spin 6
chromatography columns and centrifuged at 3200 rpm for 5 min
to remove the unincorporated [a-32P] dCTP. Repair products
were then separated by 15% urea-denaturing polyacrylamide gel
electrophoresis [70] and detected by a Pharos FX Plus Phosphor-
Imager from Bio-Rad. The full length (115 nt) of random DNA
sequence without any base lesion was 32P-labeled and run in
parallel in a DNA sequencing gel to indicate the size of the repair
products.
In vitro reconstituted BER assay
BER of an abasic lesion (a THF residue) in the context of
(GAA)20 repeats was performed by incubating 50 nM purified
APE1, 10 nM pol b, 10 nM FEN1, and 5 nM LIG I with 25 nM
(GAA)20 repeat-containing substrate with a THF residue. The 20-
ml reaction was reconstituted with the indicated concentrations of
BER enzymes and the substrate in BER reaction buffer that
contained 50 mM dNTPs, 5 mM Mg2+ and 2 mM ATP. Reaction
mixtures were assembled on ice, and incubated at 37uC for
15 min. Reactions were then terminated by transferring to 95uC
for 10 min. To isolate repair products, the template strand of the
substrate was biotinylated at the 59-end. Repair products were
incubated with avidin agarose beads (Pierce-Thermo Scientific,
Rockford, IL) in binding buffer that contained 0.1 M phosphate,
0.15 M NaCl, pH 7.2 and 1% Nonidet P-40 at 4uC for 2 h with
rotation. The agarose beads were centrifuged at 5000 rpm for
1 min and were washed three times with the binding buffer. The
repaired strands were then separated from their template strands
through incubation in 0.15 M NaOH for 15 min with rotation
under room temperature and centrifugation at 5000 rpm for
2 min. Repaired strands were then precipitated with ethanol,
dissolved in TE buffer, and stored at -20uC for subsequent size
analysis.
Probing of secondary structures by Mung Bean Nuclease
digestion
Formation of secondary structures on the template and
damaged strands of (GAA)20-containing substrates was probed
by Mung Bean Nuclease digestion. Substrates (200 nM) contain-
ing a THF residue within (GAA)20 repeat tracts were pre-
incubated with 10 nM APE1 at 37uC for 30 min to generate the
ssDNA break intermediates, followed by digestion with 2 U Mung
Bean Nuclease at 37uC for 1, 3, 5, 10 and 15 min. The 10-ml
reaction was conducted in reaction buffer containing 30 mM
sodium acetate (pH 4.6), 50 mM NaCl, 1 mM zinc acetate, and
0.01% Triton X-100. Enzymatic reactions were terminated by
2 mg proteinase K digestion at 55uC for 30 min. Reaction
mixtures were subjected to 95uC for 10 min to denature the
DNA. Substrates and digestion products were separated by 15%
urea-denaturing PAGE and detected by a PhosphorImager.
Synthesized DNA size markers were used to indicate the size of
nuclease cleavage products.
Enzymatic activity assay
Pol b DNA synthesis during BER was examined by using
25 nM oligonucleotide substrates containing (GAA)20 with a THF
residue as illustrated in Table S1. Pol b DNA synthesis in the
absence or presence of FEN1 was examined at 37uC for 15 min in
a 20-ml reaction mixture that contained BER reaction buffer with
50 mM dNTPs and 5 mM Mg2+. FEN1 cleavage activity in the
presence of pol b was examined under the same conditions used
for determining pol b activity. Pol b DNA synthesis and FEN1
cleavage during BER of a base lesion in the context of (GAA)20
repeats were also determined in 1 min, 3 min, 5 min, 10 min, and
15 min time intervals with the (GAA)20 repeat substrate
32P-
labeled at the 59- or 3’-end. Reaction mixtures were then subjected
to 95uC for 10 min in 20 ml of stopping buffer containing 95%
formamide and 2 mM EDTA to denature DNA. Repair
intermediates and products were separated by 15% urea-
denaturing PAGE and detected by a PhosphorImager. Synthe-
sized DNA size markers were run in parallel to indicate the size of
pol b synthesized products and FEN1 cleavage products.
Sizing analysis of GAA repeats by DNA fragment analysis
and GeneMapper software
Genomic DNA isolated from temozolomide treated human
lymphoblasts were amplified by a forward primer (59- GCC AAC
ATG GTG AAA CCC AGT ATC-39) and a reverse primer
tagged by a 6-carboxyfluorescein (59-6-FAM- CCA CGC CCG
GCT AAC TTT TC-39) using the Long Range PCR kit from New
England Biolabs (Ipswich, MA). Amplification of normal and
expanded GAA repeats were obtained by using the following PCR
procedure: 94uC for 20 s, 65 uC for 2 min (annealing and
extension), 20 cycles; 94uC for 20 s, 65 uC for 2 min in which the
length of this step was increased by 15 s per cycle (annealing), 65
uC for 1.5 min (extension), 17 cycles; and final extension at 65 uC
for 30 min. The length of PCR products should be (79+3n) bp
(n= number of GAA triplets). Repair products resulting from in
vitro BER in the context of (GAA)20 repeats were amplified by
PCR with a forward primer (59-CGA GTC ATC TAG CAT
CCG TA-39) and a reverse primer tagged by a 6-carboxyfluor-
escein (59-6-FAM-CA ATG AGT AAG TCT ACG TA-39). PCR
amplification was performed under the following conditions: 95uC
for 10 min, 1 cycle; 95uC for 30 s, 50uC for 30 s and 72uC for
1.5 min, 35 cycles; 72uC for 1 hr. The 6-carboxyfluorescein-
labeled PCR products were then subjected to capillary electro-
phoresis. The size of repair products was determined by DNA
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Figure 1. GAA repeat instability induced by temozolomide in the normal and FRDA lymphoblasts. (A) Lymphoblasts derived from a
normal individual were treated with 10 mM temozolomide according to the procedure described in the Materials and Methods. Panel A represents
the result from untreated cells. Panel B represents the result from the cells treated with 10 mM temozolomide. (B) FRDA patient lymphoblasts that
contained 280 GAA repeats were treated with 10 mM temozolomide according to the procedure described in the Materials and Methods. Panel A
illustrates the result from untreated cells. Panel B represents the result from temozolomide treated cells. DNA fragments including repaired products
are illustrated as individual peaks. The height of a peak represents the abundance of a repair product with a specific size. The sizes of repair products
are illustrated in nucleotides. Size standards are indicated.
doi:10.1371/journal.pone.0093464.g001
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fragment analysis (Florida International University DNA Sequenc-
ing Core Facility) with GeneMapper version 4.0 software (Applied
Biosystems, Foster City, CA, USA). Size standards, MapMarker
1000 and 400–2000 (Bioventures, Murfreesboro, TN) were run in
parallel with PCR-amplified repair products.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6
(Graphpad software, San Diego, CA). Significant differences in the
data were examined by standard two-way analysis of variance with
Tukey’s multiple comparison posttests. The significant difference
was designated at P , 0.05.
Results
Temozolomide induced large contractions and limited
expansions in the intronic GAA repeats of FRDA patient
lymphoblasts
To determine whether alkylated DNA base lesions induced in
the intronic expanded GAA repeat tracts can result in GAA repeat
instability, we initially examined the effects of temozolomide on
the instability of intronic GAA repeats in lymphoblasts from both a
normal individual and a FRDA patient. We found that
temozolomide failed to induce any length change in the intronic
GAA repeats of the non-patient cells (Figure 1A, panel B). The
GAA repeats exhibited the same length as those in the untreated
lymphoblasts that varied between 3–15 repeat units (Figure 1A,
panel A). For FRDA patient lymphoblasts that contained 280
GAA repeats (GM16207), the length of GAA repeats varied from
250 to 293 repeat units (Figure 1B, panel A). Surprisingly,
exposure of FRDA patient cells (GM16207) to 10 mM temozolo-
mide led to production of a series of GAA repeat-containing
fragments with 33–249, 253–270 and 276–309 repeat units, which
correspond to large deletion, unaltered and small expansion
products, respectively (Figure 1B, panel B). The results indicate
that temozolomide predominantly induced large repeat deletions,
but only induced limited expansions (up to 16 repeat units) in
patient lymphoblasts (Figures 1B, panel B). Thus, we conclude that
temozolomide mainly induced GAA repeat contractions in long
intronic GAA repeats in FRDA patient lymphoblasts.
Temozolomide induced ssDNA breaks in lymphoblasts
from a normal individual and FRDA patient
Because more than 80% of temozolomide-induced base lesions
are N-methylated bases that can be recognized and removed by N-
methylpurine DNA glycosylase (MPG) [64], temozolomide-
induced base lesions are mainly subjected to BER, during which
removal of an alkylated DNA base produces an abasic site that is
subsequently cleaved by APE1 leaving a 1nt-gapped DNA (i.e. an
ssDNA break intermediate). Pol b DNA synthesis then fills the
single nucleotide gap, generating a nick for ligation by LIG I or a
complex of DNA ligase IIIa and X-ray repair cross-complement-
ing protein 1 (XRCC1) [63]. We reason that ssDNA breaks
induced by temozolomide can lead to DNA slippage, which
further results in GAA repeat instability through BER. We initially
asked whether temozolomide can result in accumulation of ssDNA
Figure 2. Accumulation of ssDNA breaks induced by temozolomide in the normal and FRDA lymphoblasts. ssDNA breaks in the normal
individual lymphoblasts bearing intronic 15 GAA repeats and FRDA patient lymphoblasts bearing intronic 280 GAA repeats untreated or treated by
10 mM and 20 mM temozolomide, were measured using a comet assay under an alkaline condition according to the procedure described in the
Materials and Methods. Comet rate (A) and Oliver Tail Moment (OTM) (B) were calculated and measured. Comet rate was calculated by the equation:
Comet rate (%) = (total number of comet cells/total number of counted cells) 6100. All comet rates were obtained from three independent
experiments and expressed as mean 6 S.E. The OTM values were expressed as mean 6 S.D. from 30 individual comet cells. Two-way ANOVA with
Tukey’s multiple comparison posttests was used to determine statistically significant differences. "*" denotes P , 0.05, compared to untreated cells,
and "#" denotes P ,0.05, compared with normal lymphoblasts at the corresponding concentration of temozolomide.
doi:10.1371/journal.pone.0093464.g002
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break intermediates in FRDA lymphoblasts. To address this
question, we determined the level of temozolomide-induced
ssDNA breaks in the normal and FRDA lymphoblasts by the
comet assay under alkaline conditions (pH .13). This assay is a
fast, simple and sensitive approach for detecting ssDNA breaks
and alkali labile sites, such as an abasic site, at the single cell level.
We found that exposure of both normal and FRDA patient
lymphoblasts to 10 mM or 20 mM temozolomide for 2 hr
significantly increased the comet rate and OTM value (P,0.05)
(Figure 2), indicative of accumulation of ssDNA break interme-
diates in the cells. In addition, the comet rate and OTM value
were significantly increased with increasing concentrations of
temozolomide, indicating that the accumulation of ssDNA breaks
was temozolomide-dependent (Figure 2). Interestingly, both
untreated and temozolomide-treated FRDA patient lymphoblasts
exhibited significantly higher comet rate and OTM value than
non-patient cells (P,0.05) (Figure 2) indicating that more ssDNA
breaks and alkali labile sites accumulated in FRDA lymphoblasts
than in non-patient cells. This is consistent with previous findings
that FRDA patient cells exhibited elevated oxidative stress due to
the deficiency of the mitochondrial protein, frataxin [70,71].
BER of the normal and FRDA patient lymphoblasts
efficiently repaired a DNA base lesion
Because temozolomide significantly increased the level of
ssDNA breaks in both the normal and FRDA lymphoblasts, we
then asked if the DNA damage could be efficiently repaired by
BER in these cells. To address this, we measured BER capacity in
both the normal and FRDA patient lymphoblasts in vitro by
incubating cell extracts of lymphoblasts with a synthesized
oligonucleotide substrate with an abasic site analog, the THF
residue. The results revealed that cell extracts from both the
normal and patient lymphoblasts efficiently converted ssDNA
break intermediates into a repaired product (115 nt) (Figure 3). We
failed to observe a significant difference in the amount of repair
products between the normal (Figure 3, lane 1) and patient cells
(Figure 3, lane 2) indicating that the FRDA patient cells exhibited
the same BER capacity as the normal cells. Collectively, our results
indicate that ssDNA break intermediates induced by temozolo-
mide can be efficiently repaired by BER in FRDA lymphoblasts.
BER of an abasic lesion in the context of GAA repeats
leads to large deletions along with small expansions
To determine whether BER of an abasic lesion and its-resulting
ssDNA break intermediates can further result in GAA repeat
deletion and expansion, we examined the effects of an abasic site
on the instability of (GAA)20 repeats during BER. A (GAA)20
repeat substrate with an abasic lesion (THF residue) that
substituted for the guanine of the tenth GAA repeat was employed
to mimic the scenarios wherein a ssDNA break occurs in the
middle of a (GAA)20 repeat tract. BER of the abasic lesion was
reconstituted with purified APE1, pol b, FEN1 and LIG I. The
results revealed that the repair of a base lesion mainly resulted in a
deletion of 8 GAA repeats along with an expansion of 1–2 repeats
(Figure 4, panel B). PCR amplification of a (GAA)20 repeat-
containing marker without any damage gave no repeat expansion
or deletion products (Figure 4, panel A) indicating that the deletion
and expansion products were DNA base lesion- and repair-
dependent. The results further demonstrate that the expansion
and deletion products were from BER rather than from PCR
artifacts. Thus, our results indicate that BER of a base lesion in the
context of GAA repeats results in large GAA repeat deletion and
limited GAA repeat expansion.
Formation of single-stranded loops on the damaged and
template strands of a (GAA)20 repeat tract during BER
Because trinucleotide repeats instability is caused by the
formation of secondary structures such as hairpins and tetraplexes
[72,73], and our previous studies indicate that the formation of
hairpin structures on the template and damaged strands of a
(CTG)20 repeat tract leads to the instability of CTG repeats during
BER [52]. We therefore asked if there is a secondary structure that
can form in the context of GAA repeats to predominantly result in
GAA repeat deletion during BER given that G and A cannot base
pair with each other via a Watson-Crick base pairing. To address
this we used Mung Bean Nuclease, an enzyme that preferentially
makes a cleavage at a single-stranded DNA region, to determine
the formation of secondary structures on the damaged and
template strands of the (GAA)20 repeat substrate after APE1
incision of a THF residue in the GAA repeat tract. We found that
Mung Bean Nuclease cleavage on the template strand resulted in
products with 25 nt, 28 nt, 31 nt, 34 nt, 37 nt, 40 nt, 43 nt, 46 nt,
49 nt, 52 nt and 55 nt (Figure 5A, lane 5). Interestingly, we found
that at an early time interval of 1 min, the nuclease cleavage
mainly resulted in a product with 79 nt and two products that
were larger than 80 nt as well as a 49 nt product (Figure 5A, lane
2). At later time intervals of 3–15 min, the nuclease cleavage
generated products with 52 nt and 55 nt as well as products with
49 nt, 46 nt, 43 nt, 40 nt, 37 nt, 34 nt, 31 nt, 28 nt and 25 nt
Figure 3. BER capacity of the normal and FRDA patient
lymphoblasts. BER capacity of the normal and FRDA patient
lymphoblasts was measured by incubating a random DNA sequence
substrate containing an abasic site (a THF residue) with cell extracts of
the normal and FRDA patient lymphoblasts under the conditions
described in the Materials and Methods. Lane 1 corresponds to reaction
mixture with cell extracts of the normal lymphoblasts. Lane 2
corresponds to reaction mixture with cell extracts from FRDA patient
lymphoblasts with indicated GAA repeat length. Lane 3 corresponds to
synthesized size marker (M).
doi:10.1371/journal.pone.0093464.g003
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(Figure 5A, lanes 3–6). The cleavage pattern indicates that a small
GAA repeat loop formed upstream of the abasic lesion of the
damage strand and a small TTC repeat loop formed on the
template strand at early stage of BER. During the later stage of
BER, a large (TTC)11 loop formed on the template strand
(Figure 5C). Thus, it appears that the formation of the small loop
on the upstream damaged strand initiated the formation of the
small and large template loops. To further confirm this, we probed
secondary structures on the upstream damaged strand. The results
revealed that during the first 1 min interval, Mung Bean Nuclease
cleavage mainly resulted in products with 21 nt, 22 nt, 24 nt,
25 nt, 27 nt and 28 nt (Figure 5B, lanes 2–6). This confirmed the
formation of a small (GAA)3 loop upstream of the abasic lesion in
the (GAA)20 repeat tract on the damaged strand during the early
stage of BER (Figure 5B, lane 2, and Figure 5C). The results also
indicate that the formation of the small GAA repeat loop is
sustained through the entirety of BER, because the nuclease
cleavage products continue to exist until the later time of repair of
10 min and 15 min (Figure 5A and 5B, lanes 5–6).
Pol b DNA synthesis and FEN1 flap cleavage during BER
of an abasic lesion in a (GAA)20 repeat tract
Our previous study indicates that the formation of various
numbers and sizes of hairpins at different locations of a (CTG)20
repeat tract can result in varying efficiencies of pol b DNA
synthesis and FEN1 flap cleavage, that in turn governs CTG
repeat deletion or expansion [52]. It is possible that the formation
of small and large GAA repeat loops on the damaged and template
strands can cause small repeat expansions and large repeat
deletions by modulating the efficiency of pol b and FEN1. To test
this, we characterized the activities of pol b DNA synthesis and
FEN1 flap cleavage during BER of an abasic site (THF residue) in
the context of a (GAA)20 repeat tract. The results revealed that pol
b mainly inserted one to three repeat units during repair of the
damage in the absence and presence of 10 nM FEN1 (Figure 6,
lanes 3–5 and lanes 6–8). This indicates that pol b performed
limited DNA synthesis during the repair of the base lesion located
in the middle of the (GAA)20 repeat tract. In contrast, FEN1
removed up to nine repeats during repair of the abasic lesion
(Figure 7, lanes 3–4), indicating that FEN1 cleaved relatively larger
lengths of repeats during BER in the context of GAA repeats.
Further characterization of pol b DNA synthesis and FEN1
cleavage at different time intervals indicates that pol b synthesized
1–2 repeats during 1–5 min (Figure 8A, lanes 3–5), whereas FEN1
only removed one repeat during the same time intervals (Figure 8B,
lanes 3–5). At later time intervals of 10–15 min, pol b synthesized
3–4 repeats (Figure 8A, lanes 6–7), while FEN1 removed up to 9
repeats (Figure 8B, lanes 6–7). This indicates that pol b performed
limited DNA synthesis during both the early and later stages of
BER. FEN1 cleaved a short GAA repeat flap at the early stage, but
removed a long repeat flap at the later stage of repair. We
conclude that during BER in the context of GAA repeats, pol b
performed an inefficient DNA synthesis by inserting a limited
number of GAA repeat units (Figure 6, lanes 3–8, Figure 8A, lanes
3–7), whereas FEN1 removed a short flap at beginning of the
repair (Figure 8B, lanes 3–5), and then efficiently cleaved a
relatively longer flap cleavage at the later stage of BER (Figure 7,
lanes 3–4 and Figure 8B, lanes 6–7).
Figure 4. BER of an abasic lesion in the context of (GAA)20 repeats led to large GAA repeat deletions and small repeat expansions.
The repair of an abasic lesion (THF residue) in (GAA)20 repeats was performed by reconstituting BER with purified BER enzymes as described in the
Materials and Methods. Repaired products were then isolated and amplified by PCR and were subjected to capillary electrophoresis and DNA
fragment analysis. Panel A illustrates the results of DNA fragment analysis of a (GAA)20 repeat-containing marker without any DNA damage. Panel B
represents the DNA fragment analysis results of repair products from the reconstituted BER. Size standards are indicated.
doi:10.1371/journal.pone.0093464.g004
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Discussion
In this study, we provide the first evidence that the chemother-
apeutic DNA damaging agent temozolomide can predominantly
induce massive contractions in expanded intronic GAA repeats in
FRDA lymphoblasts (Figure 1B). We demonstrate that temozolo-
mide induces ssDNA breaks in FRDA lymphoblasts that can be
efficiently repaired through BER (Figures 2–3). Further charac-
terization on BER of an abasic lesion in the context of (GAA)20
repeats revealed that the repair of the base lesion resulted in a
large deletion of 8 GAA repeats along with limited size (1 to 2
repeat units) of repeat expansions (Figure 4). This indicates that
GAA repeat deletion and expansion was mediated by BER of base
lesions in a GAA repeat tract. We further demonstrated that the
large GAA repeat deletion was mediated by the formation of a
large single-stranded (TTC)11 loop on the template strand of the
(GAA)20 tract (Figure 5). This led to inefficient pol b synthesis of 1–
4 GAA repeats (Figures 6 and 8A) and efficient FEN1 cleavage of a
long (GAA)9 repeat flap (Figures 7 and 8B), thereby leading to a
large (eight repeats) GAA repeat deletion. We showed that the
small repeat expansions were mediated by the formation of a small
upstream GAA repeat loop and a downstream short GAA repeat
flap on the damaged strand. This led to limited pol b DNA
synthesis and removal of a short repeat flap by FEN1 resulting in
small repeat expansions. The results allow us to propose a model
that illustrates the role of BER in mediating chemotherapeutically
induced GAA repeat contractions/deletions and expansions in
which an alkylated base lesion in a GAA repeat tract is removed
by a damage specific DNA glycosylase, i.e., methylpurine DNA
glycosylase (MPG) (Figure 9). This results in an abasic site that is
59-incised by APE1, leaving a ssDNA break that leads to slippage
Figure 5. Formation of single-stranded loop structures on the damaged and template strands during BER of an abasic lesion in a
(GAA)20 repeat tract. The secondary structures formed on the damaged and template strands of the (GAA)20 repeat-containing substrate with an
abasic lesion located in the middle of the repeat tract, were probed by Mung Bean Nuclease digestion under the conditions described in the Materials
and Methods. (A) Formation of secondary structures on the template strand was probed by incubating 2 U Mung Bean Nuclease with the substrate
radiolabeled at the 5’-end of the template strand at various time intervals. Lane 1 represents the undigested substrate. Lanes 226 represent the
digestion products generated at various time intervals. Lane 7 represents synthesized size markers (M). (B) Formation of secondary structures on the
damaged strand was probed by incubating Mung Bean Nuclease with the substrate radiolabeled at the 5’-end of the damaged strand at various time
intervals. Lane 1 represents the substrate only. Lanes 226 represent the Mung Bean Nuclease cleavage products generated at various time intervals.
Lane 7 represents synthesized size markers (M). (C) Deduced loop structures formed on the damaged and template strands of the (GAA)20 repeat
substrate during BER are illustrated schematically below the gels. Mung Bean Nuclease digestion sites are indicated.
doi:10.1371/journal.pone.0093464.g005
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of the GAA repeats and the formation of a small loop at the
upstream of the ssDNA break. This subsequently triggers the
formation of a small TTC repeat loop on the template strand. Pol
b bypasses the small template loop by synthesizing 1 to 2 GAA
repeats and creates a short downstream GAA repeat flap that is
cleaved by FEN1. This leads to small GAA repeat expansions
during the early stage of BER (Figure 9, Sub-pathway 1). At the
later stage of BER, the small template TTC loop expands into a
large loop. This further results in the formation of a long GAA
flap. Pol b bypasses the template loop by synthesizing 3 to 4 GAA
repeat units. FEN1 cleaves the long repeat flap removing more
GAA repeats than pol b synthesizes and resulting in GAA repeat
deletion (Figure 9, Sub-pathway 2).
It has been a challenge to develop an effective treatment for
inherited TNR expansion-related neurodegenerative diseases.
Current treatment for FRDA focuses on improvement of frataxin
gene expression via altering epigenetic features at the frataxin gene
[47] and the easing of the neurodegenerative symptoms [46].
However, the effectiveness of the treatment is still limited by
expanded GAA repeats in the genome of FRDA patients. A
strategy of shortening expanded GAA repeats should provide
more effective treatment for FRDA and other TNR expansion-
related neurodegenerative diseases. Thus, any strategies that can
shorten expanded GAA repeats in the frataxin gene could
effectively improve frataxin gene expression, thereby reducing
the severity of FRDA symptoms. A study has shown that the
chemotherapeutic agents mitomycin C, mitoxantrone and doxo-
rubicin, as well as a monofunctional alkylating agent, ethylmetha-
nesulfonate (EMS), induced deletions of expanded CTG/CAG
repeats in the 59-untranslated region (UTR) of the myotonic
dystrophy protein kinase (DMPK) gene in myotonic dystrophy type
1 (DM1) patient lymphoblasts [51]. This suggests a potential for
employing DNA damage induced TNR deletion as a target for
treatment of TNR-expansion related neurodegeneration. Herein,
we characterized the effects of a chemotherapeutic alkylating
agent, temozolomide, on the instability of GAA repeats to explore
the possibility of employing the chemotherapeutic drug as a
potential treatment for FRDA. We found that temozolomide
induced large contractions/deletions of expanded intronic GAA
repeats in FRDA lymphoblasts, but not in a short GAA repeat
tract in non-patient cells. We further demonstrated that the GAA
repeat contractions/deletions were mediated by BER because
temozolomide-induced alkylated DNA base lesions are mainly
subjected to BER. Our results suggest that the chemotherapeutic
alkylating agent, temozolomide can be developed as a potent
therapeutic drug to treat FRDA via inducing alkylated base lesions
and BER. It should also be noted that the GAA repeats are
composed of stretches of guanines and adenines, both of which can
be readily methylated by temozolomide. This could make
Figure 6. Pol b DNA synthesis during BER of an abasic lesion in
the context of (GAA)20 repeats. Pol b DNA synthesis with the
(GAA)20 substrate containing an abasic lesion (a THF residue) was
determined by incubating the (GAA)20 substrate radiolabled at the 5’-
end of the damaged strand with increasing concentrations of pol b in
the absence or presence of 10 nM FEN1. Lane 1 corresponds to the
substrate only. Lane 2 corresponds to reaction mixtures with 50 nM
APE1. Lanes 3–5 correspond to reaction mixtures with 2, 5, and 10 nM
pol b in the absence of FEN1. Lanes 6–8 correspond to reaction
mixtures with 2, 5, and 10 nM pol b in the presence of 10 nM FEN1.
Lane 9 corresponds to synthesized size markers (M). The substrate is
illustrated schematically above the gel.
doi:10.1371/journal.pone.0093464.g006
Figure 7. FEN1 cleavage during BER of an abasic lesion in the
context of (GAA)20 repeats. FEN1 cleavage activity during repair of
an abasic lesion in the context of GAA repeats was determined by
incubating the (GAA)20-THF substrate with 10 nM and 25 nM FEN1
under the conditions described in the Materials and Methods. Lane 1
corresponds to the substrate only. Lane 2 corresponds to reaction
mixtures with 50 nM APE1. Lanes 324 correspond to reaction mixtures
with 10 nM and 25 nM FEN1 in the presence of 10 nM pol b. Lane 5
corresponds to synthesized size markers (M). The substrate was 32P-
labeled at the 3’-end of the damaged strand and illustrated
schematically above the gel.
doi:10.1371/journal.pone.0093464.g007
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expanded GAA repeats in FRDA patients a specific target for
temozolomide-induced DNA damage treatment and enhance the
effectiveness of the treatment. Moreover, as an anti-brain tumor
drug, temozolomide can readily penetrate the blood-brain barrier
and enter the cerebrospinal fluid [74]. It is conceivable that
temozolomide can efficiently diffuse into the nerve cells in the
dorsal root ganglia of FRDA patients to induce the contractions of
expanded GAA repeats at a relatively low dosage. We found that
10 mM temozolomide allowed $80% cell survival, and can
effectively contract expanded GAA repeats in FRDA patient
lymphoblasts. This dose is 20-30-fold lower than the doses used for
treatment of brain tumors in clinic (equivalent to ,270–360 mM)
[74]. Thus, it appears that the treatment of FRDA with the low
dose of temozolomide can significantly help to reduce its side-
effects, such as nausea, vomiting, headache, fatigue and anorexia
[75]. Our results demonstrate a promising therapeutic effect of
temozolomide on FRDA by contracting the expanded GAA
repeats in the genome of FRDA patients. Our results also provide
the first evidence that the temozolomide-induced GAA repeat
contraction is dependent on cellular BER capacity (Figure 3)
indicating a critical role for BER in a potential DNA base lesion-
based treatment of FRDA.
Interestingly, we observed that Mung Bean Nuclease cleavage
on the template strand of the (GAA)20 repeat substrate at the
1 min interval mainly resulted in large products with 79 nt and
.80 nt and a product with 49 nt (Figure 5A, lane 2). This
indicated that a small upstream GAA repeat loop formed on the
damaged strand prior to the formation of a large loop on the
template strand. This was further confirmed by the cleavage of
Mung Bean Nuclease on the damaged strand that generated
products 21 nt and 22 nt, 24 nt and 25 nt, as well as 27 nt and
28 nt at the first minute of BER (Figure 5B, lane 2), which
indicates the formation of an upstream (GAA)3 repeat loop. Mung
Bean Nuclease cleavage at later time intervals mainly generated
products with 55 nt, 52 nt, 49 nt, 46 nt, 43 nt, 40 nt, 37 nt, 34 nt,
31 nt, 28 nt and 25 nt (Figure 5A, lanes 3–6), which indicates the
formation of a large TTC loop on the template strand. Our results
demonstrated a sequential order in the formation of GAA repeat
loops on the damaged and template strands during BER, i.e.,
initially a small upstream GAA repeat loop formed at the damaged
strand. This in turn triggered the formation of a small loop on the
template strand that subsequently expands into a large loop
(Figure 5C).
Our results also indicate that the formation of small loops on the
damaged and template strands during the early stage of BER
allowed pol b to synthesize 1 or 2 GAA repeats (Figure 8A, lanes
3–5). This then generated a one-GAA repeat flap that was cleaved
by FEN1 (Figure 8B, lanes 3–5), thereby leading to limited repeat
expansion (one or two repeat units). However, during the later
stage of BER, a large TTC loop formed. This then created a large
flap with 9 GAA repeats. FEN1 efficiently removed the longer flap
(Figure 7, lanes 3–4, Figure 8B, lanes 6–7), whereas pol b only
Figure 8. Pol b DNA synthesis and FEN1 cleavage at various time intervals during BER of an abasic lesion in a (GAA)20 repeat tract.
(A) Pol b DNA synthesis during repair of an abasic lesion in the context of (GAA)20 repeats at different time intervals were conducted as described in
the Materials and Methods. The substrate was 32P-labeled at the 5’-end of the damaged strand. Lane 1 corresponds to the substrate only. Lane 2
corresponds to the substrate that was pre-cut by 50 nM APE1. Lanes 327 correspond to reaction mixtures with APE1 pre-cut substrate, 10 nM pol b
and 10 nM FEN1 at indicated time intervals. Lane 8 corresponds to synthesized size markers (M). (B) FEN1 cleavage during repair of an abasic lesion in
the (GAA)20-THF substrate at different time intervals were conducted as described in the Materials and Methods. The substrate was
32P-labeled at the
3’-end of the damaged strand. Lane 1 corresponds to the substrate only. Lane 2 corresponds to the substrate that was pre-cut by 50 nM APE1. Lanes
327 correspond to reaction mixtures with APE1 pre-cut substrate, 10 nM pol b and 10 nM FEN1 at indicated time intervals. Lane 8 corresponds to
synthesized size markers (M). The substrate is illustrated schematically above the gel.
doi:10.1371/journal.pone.0093464.g008
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synthesized 3–4 GAA repeats (Figure 6, lanes 3–8, Figure 8A,
lanes 6–7). This resulted in a large repeat deletion of up to 8 repeat
units. These results are consistent with those showing that only
limited GAA repeat expansions, but large deletions, were observed
in both FRDA lymphoblasts that were treated with temozolomide
(Figures 1B) and in vitro BER of an abasic lesion in the (GAA)20-
containing substrate (Figure 4). Thus, our results suggest that small
GAA repeat expansions occur before large GAA repeat deletions
can occur during BER of base lesions induced by temozolomide.
This further demonstrates a sequential production of expansion
and deletion products during BER.
It has been reported that mismatch repair (MMR) proteins,
MSH2, MSH3 and MSH6 are actively involved in GAA repeat
expansion by binding to TNR hairpins, bulges and loops [41–45].
Figure 9. A model for large GAA repeat contractions/deletions and small expansions induced by alkylating DNA base lesions via
BER. Alkylating DNA damaging agents such as temozolomide can result in methylation of a guanine and/or an adenine. Methylated bases can be
removed by N-methylpurine DNA glycosylase (MPG). Subsequently, this leaves an abasic site that is 5’-incised by APE1 generating a ssDNA break in a
GAA repeat tract. This initially causes dissociation of the upstream damaged strand and DNA slippage allowing the formation of a small upstream
GAA repeat loop (Sub-pathway 1). This further results in the formation of a small template loop and a short GAA repeat flap at the downstream of the
strand break. Pol b performs limited DNA synthesis, and FEN1 cleaves a short GAA repeat flap, thereby causing small repeat expansion (Sub-pathway
1). At a later stage of BER, the small template loop expands into a large loop allowing the dissociation of the downstream strand that subsequently
leads to the formation of a long downstream GAA repeat flap. Pol b synthesizes a limited number of repeats to bypass the template loop. FEN1 then
cleaves the long flap, resulting in a large GAA repeat contraction/deletion (Sub-pathway 2).
doi:10.1371/journal.pone.0093464.g009
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In a mismatch repair-based GAA repeat expansion model, it is
proposed that during DNA replication and transcription, DNA
misalignment will result in small loop-outs containing one or a few
triplets that can be bound and stabilized by MutSb (MSH2/
MSH3) and/or MutSa (MSH2/MSH6). This subsequently leads
to incorporation of the loop-outs into the genome causing GAA
repeat expansion [42]. Multiple rounds of misalignment and
MMR eventually result in the accumulation of multiple GAA
repeat loop-outs that lead to large GAA repeat expansions [42]. In
this study, we have discovered that BER can also be involved in
somatic expansion of GAA repeats. We observed the formation of
a (GAA)3 loop at the upstream of an abasic lesion in a (GAA)20
repeat tract (Figure 5) that led to a 1–2 GAA repeat expansion. It
is conceivable that small GAA repeat loops formed during BER
may be bound and stabilized by mismatch repair proteins leading
to accumulation of multiple small GAA repeat expansions that
lead to relatively large repeat expansion. This is supported by a
previous finding showing that enriched binding of MSH2 and
MSH3 to the intronic GAA repeats in an iPSCs derivative of
FRDA fibroblasts [45], and this is associated with promotion of
GAA repeat expansions in FRDA patient cells [76]. It is of
importance to study the coordination between MMR and BER
proteins in modulating GAA repeat instability during BER.
In this study, we have successfully developed a long-range PCR-
based DNA fragment analysis method for determining the
instability of TNR tracts that are longer than 135 repeats
(Figure 1B). Current DNA fragment analysis can only detect
trinucleotide repeat units up to 135 repeats [53]. This is because of
the low efficiency of amplifying long TNR tracts by a conventional
Taq DNA polymerase-mediated PCR. This limitation is caused by
nucleotide misincorporation by Taq DNA polymerase, which can
lead to stalling of strand extension and dissociation of the
polymerase from a long repeat-containing template strand [77].
For the long-range PCR-based DNA fragment analysis method
developed in our study, a DNA polymerase with 39-59 exonuclease
activity and a Taq DNA polymerase were simultaneously used to
carry out PCR reactions. The proofreading DNA polymerase
removes the misincorporated bases, and this further allows the Taq
polymerase to continue to synthesize DNA during amplification of
long trinucleotide repeats [77]. Thus, the long-range PCR-based
DNA fragment analysis provides a powerful tool to amplify and
determine the size of long trinucleotide repeat tracts. Currently,
the instability of TNR tracts that are longer than 135 repeats has
to be determined by small-pool PCR in combination with
Southern blot [40,43,78]. However, this approach can only
roughly estimate the length of long trinucleotide repeats. Our
newly developed DNA fragment analysis for long TNR tracts can
provide the precise number and length changes of the repeats. In
addition, our approach can detect all the possible repeat
expansions and deletions of long TNRs induced by DNA damage
and repair as well as other DNA metabolic pathways. Moreover,
the procedure of the PCR-DNA fragment analysis is relatively
simpler and faster than small-pool PCR in detecting TNR
instability.
Formation of alternative secondary structures by trinucleotide
repeats underlies their instability [79]. Long GAA repeats can
form triplex structures and sticky DNA during DNA replication.
These structures are associated with the instability of the repeats
and inhibition of frataxin gene expression. However, the roles of
such secondary structures in mediating GAA repeat instability
remain to be elucidated. In this study, we provide the first evidence
that the formation of a small upstream GAA repeat loop on the
damaged strand and a large TTC repeat loop on the template
strand plays an essential role in alkylated base lesions induced
GAA repeat deletion and expansion. We have demonstrated that
the loop structures disrupt the coordination between pol b DNA
synthesis and FEN1 cleavage of GAA repeat flaps. This ultimately
leads to large GAA repeat deletions and small expansions. This is
also consistent with our previous studies showing that clustered
hairpin structures generated in the context of CTG/CAG repeats
during BER disrupt the coordination between the repair enzymes
and promote inefficient BER, thereby leading to repeat deletions
and expansions [52]. This further suggests that the imbalanced
BER due to the formation of alternative secondary structures can
be a common mechanism underlying TNR instability induced by
various base lesions.
In summary, in this study, for the first time, we have
demonstrated that chemotherapeutically induced alkylated DNA
damage by temozolomide can predominantly lead to GAA repeat
contractions in expanded intronic GAA repeats in FRDA
lymphoblasts via a BER pathway. Our results indicate that during
BER of a base lesion in a (GAA)20 repeat tract, a small upstream
GAA repeat loop and a large TTC loop can form on the damaged
and template strands, respectively. This further results in
imbalanced pol b DNA synthesis of GAA repeats and FEN1
cleavage of the repeats, thereby causing large GAA repeat
deletions, but only small repeat expansions. Our study defines a
mechanism underlying alkylated DNA base lesion-induced GAA
repeat contractions which is mediated by BER. We suggest that
multiple rounds of DNA base alkylation lead to multiple rounds of
formation of a template loop and BER that ultimately leads to
large deletions of expanded intronic GAA repeats in FRDA
patients. In addition, we suggest that the chemotherapeutic
alkylating agent temozolomide can be potentially developed as a
drug for FRDA treatment. Moreover, we have successfully
developed a PCR-DNA fragment based approach to measure
the instability of GAA repeats that are longer than 135 repeats.
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